Skip to content

    Zensar Technologies Q1 FY27 earnings call

    ZENSARTECH
    Information Technology·30 Jul 2026
    Management Summary

    Zensar Technologies reported a mixed Q1 FY27, with revenue growing 1.1% QoQ in constant currency, driven by strong BFSI performance. However, profitability metrics saw sequential contraction due to large deal ramp-up costs and increased operational expenses. The company emphasized its AI-native transformation with the launch of ZenseAI.AgentMesh and is actively pursuing M&A opportunities to scale. While some verticals faced headwinds, management expressed confidence in Q2 outperforming Q1 and margin recovery from Q3.

    Highlights

    5
    • Revenue grew 1.1% QoQ in constant currency to $159.5 million, demonstrating continued momentum.

    • BFSI vertical showed strong growth of 8.3% sequentially in constant currency.

    • Operational metrics improved with utilization at 85.1% (+80 bps QoQ) and voluntary attrition at an industry-leading low of 9.6%.

    • Increased $10 million+ client count by 4, indicating successful client mining and reduced concentration risk.

    • Launched ZenseAI.AgentMesh, a universal enterprise platform for AI agents, marking a significant milestone in AI strategy adoption.

    Concerns

    4
    • EBITDA contracted by 150 bps sequentially due to pre-staffing/transition costs for large deals (2%) and increased other costs (1.5%).

    • PAT margin contracted by 220 bps to 12.2%.

    • Softness in select markets led to declines: Healthcare & Life Sciences (-3.8%), Manufacturing & Consumer Services (-2.3%), and Telecom, Media & Technology (-9.1%).

    • Order book for the quarter was $149.2 million, noted as a multi-quarter low, though management highlighted a high proportion of new business.

    Key financials

    Single quarter

    08 metrics
    1. 01Revenue159.5 Mn+1.1%QoQ
    2. 02Revenue (INR)+8.9%YoY
    3. 03EBITDA Margin-1.5%QoQ
    4. 04PAT Margin12.2%-2.2%QoQ
    5. 05Diluted EPS₹8+0.9%YoY

    Segment breakdown

    Banking, Financial Services and Insurance (BFSI)
    8.3% Sequential Growth (CC)
    Healthcare & Life Sciences
    -3.8% Sequential Decline
    Manufacturing & Consumer Services
    -2.3% Sequential Decline
    Telecom, Media & Technology
    -9.1% Sequential Decline
    Data Engineering and Analytics
    10.9% YoY Growth (Reported Currency)
    Cloud Infrastructure and Security Services
    5.7% YoY Growth (Reported Currency)
    Products and Platforms (including CMO services)
    1.3% YoY Growth (Reported Currency)
    Enterprise Application Services
    -3.3% YoY Decline (Reported Currency)
    List

    Order Book

    high confidence

    Total Value

    USD 149.2 million

    as of 2026-06-30

    quantified

    Inflow this qtr

    USD 149.2 million

    Pipeline

    deal pipeline tcv

    Close to 23% of the pipeline is large deals, defined as anything greater than $25 million TCV.

    "Order intake of $149.2 million is a multi-quarter low, but the proportion of new business from existing and net new clients is at an all-time high. Q1 is seasonally weak for renewals, which typically occur in Q3/Q4. Management is not unduly worried, especially after a bumper quarter with nearly $400 million in order bookings previously."

    Source:
    Prepared remarks

    Capital allocation

    2
    high confidence
    CategoryHeadline
    M&A

    Deal

    acquisition · announced

    Liquidity

    Cash USD 317.5 million

    Cash, including investments, stood at $317.5 million.

    Guidance & targets

    5
    CategoryTargetPriority
    Profitability
    EBITDA Margin
    similar to Q1 FY27
    High
    Profitability
    EBITDA Margin
    follow from Q3 onwards
    High
    Revenue
    Revenue Growth
    better than Q1 FY27
    High
    Revenue
    Large Deal Revenue Contribution
    full weight in Q3, Q4
    High
    Order Book
    Book-to-Bill Ratio
    0.9 to 1.1x of projected revenue
    High

    What to watch in Q2 FY27

    5

    EBITDA Margin Trajectory

    Q2 FY27, Q3 FY27, and Q3 FY27 onwards
    CurrentContracted by 150 bps sequentially in Q1 FY27
    TargetSimilar to Q1 FY27 in Q2 and Q3, with improvement from Q3 onwards

    Why it matters

    To verify if margin compression stabilizes and then improves as large deal ramp-up costs subside and growth priorities are met.

    And to that extent, at least for Q2 and Q3, we would expect the margins to be in the similar range as what we are seeing in Q1 because the ramp-up and growth are priority. And eventually, once we have achieved that, margins will follow from Q3 onwards.

    Risks & concerns

    6
    RiskSeverity

    Global macroeconomic uncertainty and geopolitical volatility

    The global macroeconomic backdrop remains uncertain, with geopolitical volatility, shifting trade dynamics, and evolving policy frameworks weighing on business sentiment and investment.Management acknowledged

    medium

    Softness and decline in specific verticals

    Revenues declined in Healthcare & Life Sciences (-3.8%), Manufacturing & Consumer Services (-2.3%), and Telecom, Media & Technology (-9.1%) due to broader environmental stresses and portfolio/client-specific issues.Management acknowledged

    medium

    Competitive intensity in the SME segment

    Larger peers entering the SME market, but management believes their structure is not designed for the agility required by SMBs, limiting their competitive impact.Analyst downplayed

    low

    Client concentration

    Previously a significant risk, it has been mitigated by increasing the number of $10 million+ clients by 4 this quarter.Management acknowledged

    low

    Headwind from largest client slowdown

    The headwind from the largest client has reduced, and the slowdown might be more muted going forward as there is not much further to decline.Management acknowledged

    low

    FDA decision-making slowdown and adverse decisions affecting HLS

    Slowdown in FDA decision-making and some adverse FDA decisions did not help the Healthcare & Life Sciences vertical, which focuses heavily on biotech clients.Management acknowledged

    medium

    Q&A highlights

    8

    “Yes. so we started executing this deal in mid-February. The transition is going on. But still, there was contribution from this. I don't think we would like to disclose the contribution. To your second question, even if we had not accounted for the large deal, BFSI still grew.”

    Analysts sought clarity on the organic vs. inorganic growth in the strong-performing BFSI segment, specifically the impact of a large deal, which management declined to quantify.

    asked by Shradha Agrawal

    3 min read6 chapters

    Detailed Narrative

    01

    Broader Environment and AI-Native Transformation

    The global macroeconomic environment remains uncertain, marked by geopolitical volatility🌐 and shifting trade dynamics. Despite this, the IT industry shows resilience, driven by a structural shift towards AI-native transformation. Zensar is leveraging this trend, having launched its ZenseAI.AgentMesh, a universal enterprise platform for autonomous AI agents. The company is actively introducing AI-native offerings, expanding partnerships, and investing in AI-certified talent to help clients adopt frontier AI technologies.

    02

    Q1 FY27 Financial Performance Overview

    Zensar Technologies reported a revenue of $159.5 million for Q1 FY27, reflecting a sequential constant currency growth of 1.1%. In INR terms, this translated to an 8.9% YoY growth and 4% sequential growth. However, EBITDA contracted by 150 basis points sequentially, and PAT margin stood at 12.2%, contracting by 220 basis points. This contraction was primarily attributed to pre-staffing and transition costs for large deal setups (around 2%) and increased operational expenses like travel, visa, and training (around 1.5%), partially offset by positive forex impact (0.8%) and management bonus reversals (1.3%).

    03

    Operational Metrics and Talent Management

    The company demonstrated strong operational execution, with utilization improving by 80 basis points sequentially to 85.1%. Workforce expanded by 5.2% sequentially, with a gross addition of 1,451 employees, 50% higher than the previous quarter. Voluntary attrition remained at an industry-leading low of 9.6% for the sixth consecutive quarter. Zensar also increased its $10 million+ client count by 4, indicating effective client mining and reduced concentration risk. The company was ranked 6th in India's best companies to work for 2026 and 1st in the IT services sector.

    04

    Vertical and Service Line Performance

    The Banking, Financial Services, and Insurance (BFSI) vertical was a strong growth driver, achieving 8.3% sequential growth in constant currency, even excluding the contribution from a large deal that began ramping up in mid-February. However, other sectors experienced softness, with Healthcare & Life Sciences declining 3.8%, Manufacturing & Consumer Services down 2.3%, and Telecom, Media & Technology seeing a 9.1% decline. On a YoY reported currency basis, Data Engineering and Analytics grew 10.9%, Cloud Infrastructure and Security Services grew 5.7%, and Products and Platforms grew 1.3%, while Enterprise Application Services declined 3.3%.

    05

    Order Book and Pipeline Commentary

    The order book for Q1 FY27 stood at $149.2 million, which was noted as a multi-quarter low. However, management highlighted that the proportion of new business (from existing and net new clients) within this order book was at an all-time high. They also clarified that Q1 is typically a seasonally weak quarter for renewals, which are more concentrated in Q3 and Q4. The company aims to maintain a book-to-bill ratio of 0.9 to 1.1x of projected revenue. The deal pipeline is healthy, with approximately 23% comprising large deals (defined as over $25 million TCV).

    06

    Strategic Priorities and M&A Outlook

    Zensar's top priorities for the next two quarters include becoming an AI-native organization for itself and its clients, ensuring a smooth ramp-up of the mega deal, and investing in SG&A for revenue growth. The company is actively looking to deploy its healthy cash balance of $317.5 million for strategic M&A. Management is targeting scaled assets, not tuck-ins, with revenue in the range of $150-200 million or more, believing current market pricing for such assets is favorable. They are currently evaluating 2-3 potential acquisition targets.

    This is an AI-generated summary of a publicly available earnings call transcript.